The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.
Etiology of Insulin Resistance
Open accessAbstract
Type 2 diabetes mellitus is a major cause of morbidity and mortality worldwide, and the prevalence is set to increase dramatically over the coming decades. Understanding the metabolic pathways that lead to type 2 diabetes is therefore an important healthcare objective. Novel investigational techniques based on magnetic resonance spectroscopy (MRS) have allowed real-time insight into the molecular defects in patients with type 2 diabetes, revealing that insulin resistance is a product of decreased insulin-stimulated skeletal muscle glycogen synthesis, which can mostly be attributed to decreased insulin-stimulated glucose transport (Glut 4) activity. This defect appears to be a result of intracellular lipid-induced inhibition of insulin-stimulated insulin-receptor substrate (IRS)-1 tyrosine phosphorylation resulting in reduced IRS-1-associated phosphatidyl inositol 3 kinase activity. The hypothesis that insulin resistance is a result of accumulation of intracellular lipid metabolites (e.g., fatty acyl CoAs, diacylglycerol) in skeletal muscle and hepatocytes is supported by observations in patients and mouse models of lipodystrophy. Furthermore, the increase in hepatic insulin sensitivity observed in patients with type 2 diabetes following weight loss is also accompanied by a significant reduction in intrahepatic fat without any changes in circulating adipocytokines (interleukin-6, resistin, leptin). Finally, recent MRS studies in healthy, lean, elderly subjects and lean insulin-resistant offspring of parents with type 2 diabetes have demonstrated that reduced mitochondrial activity may also lead to increased intramyocellular lipid content and insulin resistance in skeletal muscle in these individuals. In summary, in vivo MRS has proved to be an important tool for elucidating the causal chain of events that causes insulin resistance. Understanding the cellular mechanism(s) of insulin resistance in turn offers the prospect of better targeted and more effective therapeutic interventions for treatment and prevention of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an increased intramyocellar fat content and fatty acid metabolites have been shown to play a pivotal role in the development of insulin resistance in skeletal muscle [11–15].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [13]
In the citing paper
“Dysregulation of fatty acid metabolism plays a pivotal role in the pathogenesis of insulin resistance in skeletal muscle.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,379
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationBraissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Self-citationMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
Self-citationMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Self-citation
Flagged first, then by citations
2 of the 56 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Williamson, 2004, Primary prevention of type 2 diabetes mellitus by lifestyle intervention, Ann Intern Med, 40, 951
- Szczepaniak, 1999, Measurement of intracellular triglyceride stores by 1H spectroscopy, Am J Physiol, 276, E977
- Londos, 1996, Perilipin, Int J Obes Relat Metab Disord, 20, S97
Cited by
Sorted by citations
Items 401–500 of 825
Tumor necrosis factor alpha in peripheral neuropathy in type 2 diabetes mellitus
Sheikh, W. M. E., Alahmar, I. E., Salem, G. M., & El-Sheikh, M. A. (2019) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-019-0080-0 · Cited by 23
Chang, W.-C., Kuo, P.-L., Chen, C.-W., Wu, J. S., & Shen, S. (2015) · Food Research International · doi:10.1016/j.foodres.2015.04.010 · Cited by 26
Hamilton, D. L., Findlay, J. A., Montagut, G., Meakin, P. J., Bestow, D., Jalicy, S. M., & Ashford, M. L. J. (2014) · Diabetologia · doi:10.1007/s00125-014-3269-x · Cited by 20
“However, the first detectable defect in individuals predisposed to type 2 diabetes is altered responsiveness of skeletal muscle to insulin [1, 2], the principal site for insulinstimulated glucose disposal [3].”
BackgroundLópez-Pascual, A., Urrutia-Sarratea, A., Lorente‐Cebrián, S., Martínez, J. A., & González‐Muniesa, P. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2695289 · Cited by 25
“New therapeutic approaches should identify additional targets [11], offering a more directed and therefore effective treatment for type 2 diabetes [6].”
BackgroundCheng, Y., Chen, Y., Tzeng, C., Chen, H., Tsai, C., Lee, Y., Lin, J., Lai, Y., & Chang, S. (2012) · Phytotherapy Research · doi:10.1002/ptr.3709 · Cited by 23
Effects of exposure to malathion on blood glucose concentration: a meta-analysis
Ramírez‐Vargas, M. A., Flores‐Alfaro, E., Urióstegui-Acosta, M., Fitz, P. Á., Parra‐Rojas, I., & Moreno‐Godínez, M. E. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-0890-5 · Cited by 23
“Insulin resistance is associated with multiple risk factors, such as genetic factors, a sedentary lifestyle, a Western diet, and obesity (Petersen and Shulman 2006), while enhanced hepatic glucose production occurs in response to hepatic or tissue damage (Li and Messina 2009).”
BackgroundCoín‐Aragüez, L., Pavón, F. J., Contreras, A., Gentile, A., Lhamyani, S., de Diego‐Otero, Y., Casado, Y., Oliva‐Olivera, W., Olveira, G., Tinahones, F. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35759-9 · Cited by 23
Pathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_2 · Cited by 24
Corneal dendritic cells in diabetes mellitus: A narrative review
Liu, F., Liu, C., Lee, I. X. Y., Lin, M. T. Y., & Liu, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1078660 · Cited by 26
“Aging has been linked to diabetes through several mechanisms, including age-associated insulin resistance and age-dependent disruption of insulin production (93, 94).”
BackgroundGavin, T. P., Sloan, R. C., Lukosius, E. Z., Reed, M. A., Pender, J. R., Boghossian, V., Carter, J. J., McKernie, R. D., Parikh, K., Price, J. W., et al. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0304-y · Cited by 23
“Skeletal muscle insulin resistance is a hallmark decrement in T2DM in humans [8, 22] and has been proposed to be the precipitating event leading to type 2 diabetes [ 22 ].”
BackgroundInfluentialInsulin resistance and lipid disorders
Miccoli, R., Keyzer, D. D., Penno, D. G., & Prato, D. S. D. (2008) · Future Lipidology · doi:10.2217/17460875.3.6.651 · Cited by 24
Ussher, J. R., Jaswal, J. S., Wagg, C. S., Armstrong, H. E., Lopaschuk, D. G., Keung, W., & Lopaschuk, G. D. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00009.2009 · Cited by 23
Zhong, X., Ke, C., Cai, Z., Wu, H., Ye, Y., Liang, X., Yu, L., Jiang, S., Shen, J., Wang, L., et al. (2020) · Aging · doi:10.18632/aging.103658 · Cited by 23
“This step is mediated via the insulin-regulated translocation of GLUT4 from intracellular vesicles to the plasma membrane [26].”
BackgroundLaffer, C. L., & Elijovich, F. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00423 · Cited by 23
“Diacylglycerol-stimulated PKC isoforms serine-phosphorylate IRS-1 and IRS-2, inactivating the downstream PI3-kinase needed for translocation of GLUT 4 to the cell membrane.(34) A high salt intake may enhance this mechanism because it results in a 33% increase in plasma-free fatty acids.”
Abdollahi, S., Kazemi, A., de Souza, R. J., Clark, C. C. T., & Soltani, S. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.038 · Cited by 23
Qi, J., Yang, B., Ren, C., Fu, J. P., & Zhang, J. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1564386 · Cited by 23
“It has been widely accepted that lipid accumulation and oxidative stress are strongly correlated with the IR in peripheral tissues (muscle and liver) [31–37].”
BackgroundRyu, H. S., Park, S., Ma, D., Zhang, J., & Lee, W. (2011) · PLoS ONE · doi:10.1371/annotation/2faafaa7-e359-4711-af5b-3597c705388d · Cited by 22
Solanum anguivi Lam. Fruits: Their Potential Effects on Type 2 Diabetes Mellitus
Nakitto, A. M. S., Muyonga, J. H., Byaruhanga, Y. B., & Wagner, A. E. (2021) · Molecules · doi:10.3390/molecules26072044 · Cited by 21
“Increased amounts of adipose tissue and visceral fat in obesity lead to ectopic fat accumulation in the liver, muscle, and pancreas, and thus, IR ensues [67].”
BackgroundBi, Y., Wu, W., Shi, J., Liang, H., Yin, W., Chen, Y., Tang, S., Cao, S., Cai, M., Shen, S., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3136-1 · Cited by 21
Gysel, T., Calders, P., Cambier, D. C., de Mettelinge, T. R., Jm, K., Taes, Y., Zmierczak, H., & Goemaere, S. (2014) · PubMed · Cited by 21
Insulin Resistance and Impaired Mitochondrial Function in Obese Adolescent Girls
Slattery, M. J., Bredella, M. A., Thakur, H., Torriani, M., & Misra, M. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0100 · Cited by 21
“Mitochondrial function predisposes adults to IMCL accumulation,(9) and IMCL accumulation may lead to IR.(9,33) Given that IR peaks during adolescence, this period provides a unique opportunity (1) to study the association of mitochondrial function with IMCL and IR, and (2) for intervention that may prevent long-term h…”
BackgroundInfluentialPolymorphism of the renalase gene in gestational diabetes mellitus
Fatima, S. S., Jamil, Z., Alam, F., Malik, H. Z., Madhani, S. I., Ahmad, M. S., Shabbir, T., Rehmani, M. N., & Rabbani, A. (2016) · Endocrine · doi:10.1007/s12020-016-1058-7 · Cited by 21
How Do I Fatten Thee? Let Me Count the Ways…
Coleman, R. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.004 · Cited by 21
Heidarian, E., Kopaei, M. R., & Ashrafi, K. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 20
Sharma, N., Navik, U., & Tikoo, K. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108442 · Cited by 20
Akintoye, O. O., Owoyele, B. V., Fabunmi, O. A., Raimi, T. H., Oniyide, A. A., Akintoye, A. O., Ajibare, A. J., Ajayi, D. D., & Adeleye, G. S. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04377 · Cited by 20
“Insulin resistance (IR) is impairment in the function of insulin target cells such as liver cells, adipocytes and musculoskeletal cells in response to cellular insulin actions (Petersen and Shulman, 2006; Sesti, 2006).”
BackgroundRelationship between insulin sensitivity and gene expression in human skeletal muscle
Parikh, H. M., Elgzyri, T., Alibegovic, A. C., Hiscock, N. J., Ekström, O., Eriksson, K., Vaag, A. A., Groop, L., Ström, K., & Hansson, O. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00687-9 · Cited by 20
Intracellular lipid accumulation and shift during diabetes progression
Wolf, P. S., Winhofer, Y., Anderwald, C. H., Krššák, M., & Krebs, M. (2014) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-014-0292-y · Cited by 20
Malek, R., Ajili, F., Assaad-Khalil, S. H., Shinde, A., Chen, J. W., & van den Berg, E. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.11.002 · Cited by 20
“[3] Petersen KF, Shulman GI.”
Effect of silymarin on liver phoshpatidate phosphohydrolase in hyperlipidemic rats
Heidarian, E., & Rafieian‐Kopaei, M. (2012) · Cited by 20
Ruiz-Narváez, E., Sacks, F. M., & Campos, H. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1932 · Cited by 20
Systemic and renal growth hormone–IGF1 axis involvement in a mouse model of type 2 diabetes
Segev, Y., Eshet, R., Yakir, O., Haim, N., Phillip, M., & Landau, D. (2007) · Diabetologia · doi:10.1007/s00125-007-0663-7 · Cited by 20
“In addition, insulin resistance is an early and pivotal change [3].”
Stem Cells as a Treatment for Chronic Liver Disease and Diabetes
Levičar, N., Dimarakis, I., Flores, C., Tracey, J., Gordon, M. Y., & Habib, N. A. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68976-8_11 · Cited by 20
“The incidence of type 2 (adult onset or insulin resistant) diabetes is increasing globally and has reached pandemic proportions (Petersen and Shulman 2006).”
BackgroundInsulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 20
Self-citationShenoy, A., Buttar, H. S., Dicholkar, P., Kaur, G., & Chintamaneni, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819815-5.00017-3 · Cited by 21
ZHANG, Y., Zhao, Y., GAO, Y.-F., Fan, Z., LIU, M.-Y., CAI, X.-Y., Xia, Z., & Gao, C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3124 · Cited by 20
“Insulin resistance has a fundamental role in the development of obesity and type 2 diabetes mellitus (1,2).”
Diabetes Mellitus: New Challenges and Innovative Therapies
Sena, C. M., Bento, C. F., Pereira, P., Marquês, F., & Seiça, R. M. F. (2013) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5971-8_3 · Cited by 20
XIONG, Z.-D., Li, P.-G., & Mu, T. (2009) · Agricultural Sciences in China · doi:10.1016/s1671-2927(08)60263-1 · Cited by 19
Sharif, A., Ravindran, V. K., Dunseath, G. J., Luzio, S. D., Owens, D. R., & Baboolal, K. (2010) · Transplantation · doi:10.1097/tp.0b013e3181bd06d2 · Cited by 19
“Insulin resistance, by direct and indirect effects on skeletal muscle, is implicated in glucose intolerance, dyslipidemia, and hypertension (12).”
BackgroundNg, Y., Ramm, G., & James, D. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060632 · Cited by 19
Williams, S. K., Fiscella, K. A., Winters, P., Martins, D., & Ogedegbe, G. G. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.02.002 · Cited by 19
“Insulin resistance (IR) is associated with type 2 Diabetes Mellitus (DM)[8] and disproportionately affects Blacks more than Whites [9].”
Dufour, S., & Petersen, K. F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1747 · Cited by 18
Self-citationVaitheesvaran, B., Chueh, F., Xu, J., Trujillo, C., Saad, M. F., Lee, W. N. P., McGuinness, O. P., & Kurland, I. J. (2009) · Metabolomics · doi:10.1007/s11306-009-0190-2 · Cited by 18
“Signaling cascades are also affected by the intracellular accumulation of lipids (Petersen and Shulman 2006; Shulman 2000) However, genetic defects possibly resulting in metabolic inflexibility may not be insulin resistant.”
BackgroundHeidarian, E., Jafari-Dehkordi, E., & Seidkhani‐Nahal, A. (2011) · Research Repository Portal (Ilam University of Medical Sciences) · doi:10.5897/jmpr.9000852 · Cited by 18
Micronutrient deficiency, a novel nutritional risk factor for insulin resistance and Syndrom X
Ekpenyong, C. E. (2018) · Archive of Food and Nutritional Science · doi:10.29328/journal.afns.1001013 · Cited by 19
The correlation between body fat distribution and insulin resistance in elderly.
Dwimartutie, N., Setiati, S., & Oemardi, M. (2010) · PubMed · Cited by 18
Sun, R., Wu, Y., Hou, W., Sun, Z., Wang, Y.-X., Wei, H., Mo, W., & Yu, M. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.11.011 · Cited by 18
Bergia, R. E., Kim, J. E., & Campbell, W. W. (2018) · International Journal of Endocrinology · doi:10.1155/2018/2751250 · Cited by 19
“IMAT is thought to exert its deleterious effects primarily through impairing insulin action and glucose metabolism [45, 46].”
BackgroundRenin-angiotensin system activation in renal adipogenesis
Sui, Y., Zhao, H., Fan, R., Guan, J. Z., He, L., Lee, H. M., Chan, J. C. N., & Tong, P. C. Y. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00445.2009 · Cited by 17
Álvarez, C., Ramírez‐Campillo, R., Henríquez‐Olguín, C., Castro‐Sepúlveda, M., Carrasco, V., & Martínez‐Salazar, C. (2014) · Revista médica de Chile · doi:10.4067/s0034-98872014000400007 · Cited by 17
The evolution of insulin resistance in muscle of the glucose infused rat
Brandon, A. E., Hoy, A. J., Wright, L. E., Turner, N. A., Hegarty, B. D., Iseli, T. J., Xu, X. J., Cooney, G. J., Saha, A. K., Ruderman, N. B., et al. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.03.008 · Cited by 17
Matsumoto, C., Koike, A., Tanaka, R., & Fujimori, K. (2019) · Molecules · doi:10.3390/molecules24091668 · Cited by 17
“For activation of IRS-1, its serine residue is phosphorylated, resulting in enhanced IRS-1-associated PI3K activities [32].”
BackgroundGerena, Y., Skolasky, R. L., Velez, J. M., Toro-Nieves, D., Mayo, R., Nath, A., & Wojna, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037358 · Cited by 17
“However, the observation of decreased IRS-1 tyrosine phosphorylation is consistent with insulin resistance [65,66].”
BackgroundHolness, M. J., Smith, N. D., Greenwood, G. K., & Sugden, M. C. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00375.2006 · Cited by 17
Serum Resistin: Physiology, Pathophysiology and Implications for Heart Failure
Bhalla, V., Kalogeropoulos, A. P., Georgiopoulou, V. V., & Butler, J. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.17 · Cited by 17
Arregui, M., Buijsse, B., Stefan, N., Corella, D., Fisher, E., di Giuseppe, R., Coltell, Ó., Knüppel, S., Aleksandrova, K., Joost, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048338 · Cited by 16
“Both these conditions have been associated with insulin resistance [4].”
BackgroundRodrigues, L., Crisóstomo, J., Matafome, P. N., Louro, T. M., Nunes, E., & Seiça, R. M. F. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-011-0108-0 · Cited by 16
“The imbalance between ingested and expended calories is responsible for the deregulation of lipid storage: instead of being accumulated in adipose tissue, lipids are diverted to other organs as skeletal muscle and liver, reducing the glucose consumption and increasing lipid oxidation [1, 14, 18, 20 ].”
BackgroundInfluentialOvercoming insulin resistance with CNTF
Ahima, R. S. (2006) · Nature Medicine · doi:10.1038/nm0506-511 · Cited by 16
Roca-Rodríguez, M. D. M., Bekay, R. E., Garrido‐Sánchez, L., Gómez‐Serrano, M., Coín‐Aragüez, L., Oliva‐Olivera, W., Lhamyani, S., Clemente‐Postigo, M., García‐Santos, E., Díaz, R. D. L., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4132 · Cited by 16
“PTHrP levels were measured by enzyme immunoassay (ELISA) kits (PTHrP [1–34], Phoenix Pharma-”
MethodINSR gene variation is associated with decreased insulin sensitivity in Iraqi women with PCOs.
Mutib, M. T., Hamdan, F. B., & Al-Salihi, A. R. (2014) · Europe PMC (PubMed Central) · Cited by 16
Electrochemical Glucose Sensors and Their Application in Diabetes Management
Heller, A., & Feldman, B. (2013) · Modern aspects of electrochemistry · doi:10.1007/978-1-4614-6148-7_5 · Cited by 16
Kim, T., Leitner, J. W., Adochio, R., & Draznin, B. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.121 · Cited by 17
Plant Foods, Healthy Plant-Based Diets, and Type 2 Diabetes: A Review of the Evidence
del Carmen Fernández-Fígares Jiménez, M. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuad099 · Cited by 20
Gavin, T. P., Ernst, J. M., Caudill, S. E., Dohm, G. L., Pories, W. J., Dar, M. S., & Reed, M. A. (2014) · Surgery · doi:10.1016/j.surg.2014.02.005 · Cited by 15
Meshkani, R., & Adeli, K. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 15
Choi, E. M., Suh, K. S., Jung, W., Park, S. Y., Chin, S. O., Rhee, S. Y., Pak, Y. K., & Chon, S. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3664 · Cited by 15
Akt activation by insulin treatment attenuates cachexia in Walker‐256 tumor‐bearing rats
Silva, F. D. F., de Morais, H., Silva, M. O., da Silva, F. G., Croffi, R. V., Serrano‐Nascimento, C., Graciano, M. F. R., Carpinelli, Â. R., Bazotte, R. B., & de Souza, H. M. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29682 · Cited by 15
Chen, D., Jia, D. T., Wu, X., Shi, K., Ren, C., Dou, Y., Guo, M., Wang, J., Ma, M., Wu, Z., et al. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13302 · Cited by 15
Park, T., Lee, S., Kim, H., Kim, K., Kim, Y. J., Jeong, I., Do, W.-N., & Lee, H.-J. (2009) · The Korean Journal of Food And Nutrition · Cited by 15
Nakatani, K., Nakamoto, Y., & Togashi, K. (2012) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e328352290f · Cited by 15
ANTIOXIDANT ENZYME LEVELS AS MARKERS FOR TYPE 2 DIABETES MELLITUS
Verma, S., Sagar, N., Shukla, K., Abbas, M., & Banerjee, M. (2013) · International Journal of Bioassays · doi:10.21746/ijbio.2013.04.0023 · Cited by 15
Roberts‐Thomson, K. M., Betik, A. C., Premilovac, D., Rattigan, S., Richards, S. M., Ross, R. M., Russell, R., Kaur, G., Parker, L., & Keske, M. A. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13237 · Cited by 17
Zhang, W., Meng, J., Liu, Q., Makinde, E. A., Qing, L., & Olatunji, O. J. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.201900661 · Cited by 15
“Type 2 diabetes mellitus (T2DM), which accounts for approximately 90% of the global reported cases of DM, bears the hallmark of insulin resistance (IR) and malfunctioning of the pancreatic β-cell.[4,7,8] In DM, the persistent chronic hyperglycemic state plays a pivotal role in impairment and failure of various organs…”
BackgroundWang, L., Guo, Y., Pan, M., Li, X., Huang, D., Liu, Y., Wu, C., Zhang, W., & Mai, K. (2021) · Genes · doi:10.3390/genes12020297 · Cited by 15
“However, carbohydrate metabolism is not the sole cause of dysglycemia; lipid metabolism is also one of the reasons [43,44].”
BackgroundZhang, X.-D., Yan, J., Yan, G., Sun, X.-Y., Ji, J., Li, Y., Hu, Y., & Wang, H. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.104 · Cited by 14
MUSIL, F., ŠMAHELOVÁ, A., BLÁHA, V., HYŠPLER, R., TICHÁ, A., LESNÁ, J., ZADÁK, Z., & SOBOTKA, L. (2013) · Physiological Research · doi:10.33549/physiolres.932381 · Cited by 12
“%) were determined before the initiation of every hyperinsulinemic-euglycemic clamp.”
BackgroundMethodAli, M. Y., Park, S. E., Seong, S. H., Zamponi, G. W., Jung, H. A., & Choi, J. S. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110452 · Cited by 14
Role of Quercetin in DNA Repair: Possible Target to Combat Drug Resistance in Diabetes
Hussain, Y., Abdullah, Khan, F., Alam, W., Sardar, H., Khan, M. A., Shen, X., & Khan, H. Z. (2024) · Current Drug Targets · doi:10.2174/0113894501302098240430164446 · Cited by 14
Glycaemic load is associated with insulin resistance in older Australian women
O’Sullivan, T. A., Bremner, A., O'Neill, S., & Lyons‐Wall, P. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.115 · Cited by 14
“Although the precise cellular mechanisms of insulin resistance are not yet clear (Shulman, 2000; Petersen and Shulman, 2006), our finding is supported by the proposed mechanisms to explain how high glycaemic intakes could promote insulin resistance.”
BackgroundPioglitazone improves insulin sensitivity and reduces weight loss in Walker-256 tumor-bearing rats
Silva, F. D. F., Ortiz‐Silva, M., Galia, W. B. D. S., Cassolla, P., Graciano, M. F. R., Zaia, C. T. B. V., Zaia, D. A. M., Carpinelli, Â. R., da Silva, F. G., & de Souza, H. M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.12.016 · Cited by 14
Rhinesmith, T., Turkette, T., & Root-Bernstein, R. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122602 · Cited by 15
“As in T1DM, increased serum concentrations of fatty acids (FAs), and their subsequent metabolites may trigger inhibitory phosphorylation of insulin signaling pathway elements [4].”
BackgroundMetabolic remodeling in chronic heart failure
Wang, J., & Guo, T. (2013) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1300137 · Cited by 14
“Insulin resistance is prevalent in CHF and its potential mechanisms (Petersen and Shulman, 2006; Tuunanen and Knuuti, 2011) contain: chronically increased sympathetic nervous system (SNS) activity which leads to decreased insulin secretion, insulin responsiveness, and skeletal muscle blood flow.”
BackgroundCrisóstomo, J., Rodrigues, L., Matafome, P. N., Amaral, C., Nunes, E., Louro, T. M., Monteiro, P. F., & Seiça, R. M. F. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510000164 · Cited by 14
“Various studies reported that increased circulating plasma levels of TAG and NEFA contribute to insulin resistance in peripheral tissues such as skeletal muscle((2,7,27)).”
BackgroundParis, T., George, E. S., Roberts, S. K., & Tierney, A. C. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000890 · Cited by 15
MG53 and disordered metabolism in striated muscle
Hu, X., & Xiao, R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.013 · Cited by 13
Silvestri, E., Cioffi, F., Matteis, R. D., Senese, R., de Lange, P., Coppola, M., Salzano, A. M., Scaloni, A., Ceccarelli, M., Goglia, F., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00194 · Cited by 15
“In skeletal muscle, increased fatty acids uptake and corresponding impaired molecular utilization contribute to the accumulation of lipids leading to lipotoxicity and, thus, to insulin resistance (IR) (Falholt et al., 1988; Levin et al., 2001; Adams et al., 2004; Petersen and Shulman, 2006; Sabin et al., 2007; Koves e…”
BackgroundSerum Resistin Level in Obese Male Children
Amirhakimi, A., Karamifar, H., Moravej, H., & Amirhakimi, G. (2011) · Journal of Obesity · doi:10.1155/2011/953410 · Cited by 15
Reactive Oxygen Species in the Induction of Toxicity
Lenaz, G., & Strocchi, P. (2009) · Wiley eBooks · doi:10.1002/9780470744307.gat024 · Cited by 15
Molecular Mechanisms of Insulin Resistance
Draznin, B. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_4 · Cited by 13
Пискунов, А. К. (2010) · Neurochemical Journal · doi:10.1134/s1819712410010101 · Cited by 13
Timely Bolus Insulin for Glucose Control during Cardiopulmonary Bypass
Kruger, C., Sidebotham, D. A., Brown, A. J., Singh, H. K., & Merry, A. (2012) · Journal of ExtraCorporeal Technology · doi:10.1051/ject/201244034 · Cited by 13
Gerena, Y., Menéndez‐Delmestre, R., Skolasky, R. L., Hechavarría, R., Pérez, S., Hilera, C., González, C., Nath, A., & Wojna, V. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-014-0310-2 · Cited by 13
“Nevertheless, we previously observed in these patients that increased levels of plasma sIR correlated with a significant decrease in IRS-1 tyrosine phosphorylation in CSF leukocytes, a finding that is consistent with insulin resistance (Gerena et al. 2012; Sesti 2006; Petersen and Shulman 2006).”
BackgroundAdiponectin is related to intramyocellular lipid content in non-diabetic adults
Godoy‐Matos, A. F., Bahia, L., Domingues, R. C., Sicuro, F. L., Tambascia, M. A., Geloneze, B., Kraemer‐Aguiar, L. G., & Bouskela, E. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346608 · Cited by 13
Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese
Galli‐Τsinopoulou, A., Grammatikopoulou, M. G., Stylianou, C., Emmanouilidou, E., & Kokka, P. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346646 · Cited by 13
Ghrelin—a new player in glucose homeostasis?
Ahima, R. S. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.006 · Cited by 13
Lewis, L., Valvi, D., Gedaly, R., & Martí, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1621759 · Cited by 12
“In conditions like type 2 diabetes and obesity, when DY m is impaired, there is a disruption of the electrochemical gradient necessary for the import of substrates like pyruvate and fatty acids (102 – 104).”
Tomoo, K., Szramowski, M., Pinal, R., Meyer, J. M., Zhang, Y., Murray‐Kolb, L. E., & Henderson, G. C. (2024) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00894.2023 · Cited by 12
Ectopic Fat Deposition on Insulin Sensitivity: Correlation of Hepatocellular Lipid Content andMValue
Hong, B. S., Li, Y., Lai, S., Liu, J., Guan, H., Ke, W., He, X., & Li, Y. (2016) · Journal of Diabetes Research · doi:10.1155/2016/3684831 · Cited by 12
“Insulin resistance promotes hydrolysis of triglycerides and release of free fatty acids from adipose tissues, reduces glucose uptake inmuscle cells, impairs glycogen synthesis, and increases gluconeogenesis, lipogenesis, and synthesis of CRP in the liver [2, 3].”
BackgroundMinami, S., Yokota, N., & Kawahara, H. (2020) · Biology Open · doi:10.1242/bio.047324 · Cited by 11
“Obesityand type 2 diabetes are characterized by insulin resistance (Zierath et al., 1996; Petersen and Shulman, 2006; Bogan, 2012; Foley and Klip, 2014; Aslamy and Thurmond, 2017).”
Galia, W. B. D. S., Biazi, G. R., Frasson‐Uemura, I. G., Miksza, D. R., Zaia, C. T. B. V., Zaia, D. A. M., de Souza, H. M., & Bertolini, G. L. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3637 · Cited by 14
“Increased FFA is another factor that can impair insulin signalling.(32,33) However, FFA was not changed in rats with early (8 hours) sepsis, excluding its”
Background
Metadata
- Authors
- Petersen, K. F., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 119
- Issue
- 5
- Pages
- S10-S16
- ISSN
- 0002-9343 (ISSN-L)
- PMC
- PMC2995525
- OpenAlex
- W1982488301
- Cited by
- 825
- References
- 56
- Citations by year
- 2026: 19 · 2025: 25 · 2024: 18 · 2023: 26 · 2022: 18 · 2021: 34 · 2020: 31 · 2019: 26 · 2018: 25 · 2017: 27 · 2016: 44 · 2015: 41 · 2014: 55 · 2013: 52 · 2012: 43
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG023686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040936)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, type 2 diabetes, IRS-1 tyrosine phosphorylation, PI3K signaling, intracellular lipid accumulation, fatty acyl-CoA, diacylglycerol, lipodystrophy, hepatic insulin sensitivity, weight loss, intrahepatic fat, mitochondrial dysfunction, intramyocellular lipid, magnetic resonance spectroscopy, adipokines
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Insulin Resistance, Mitochondria, Magnetic Resonance Spectroscopy, Obesity, Phosphoproteins, Weight Loss, Thiazolidinediones, Glucose Transporter Type 4, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review